ETF Holdings Breakdown of KURA

KURA institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	39,396	USD 356,534
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	12,822	USD 116,039
2025-09-26	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	96,698	USD 875,117
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	51,277	USD 464,057
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	51,277	USD 464,057
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	647	USD 5,855 7.6%
Total =		252,117	USD 2,281,659

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with KURA

Kura Oncology (NASDAQ:KURA) Shares Gap Up After Insider Buying Activity

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $8.01, but opened at $8.62. Kura Oncology shares last traded at $8.36, with a volume of 819,759 shares changing hands. Specifically, CEO Troy Edward Wilson purchased 50,000 shares of […] - 2025-09-11 02:33:48

Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.10 Consensus Price Target from Brokerages

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong […] - 2025-09-09 02:46:57

Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to […] - 2025-08-12 03:01:02

Kura Oncology, Inc. (NASDAQ:KURA) Shares Bought by Cwm LLC

Cwm LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 892.8% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 28,353 shares of the company’s stock after acquiring an additional 25,497 shares during the quarter. Cwm LLC’s holdings in […] - 2025-07-28 05:02:47

Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.50 Average PT from Analysts

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy […] - 2025-07-21 02:45:06

SG Americas Securities LLC Decreases Stake in Kura Oncology, Inc. (NASDAQ:KURA)

SG Americas Securities LLC cut its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 15.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,121 shares of the company’s stock after selling 7,918 shares during the period. SG […] - 2025-06-27 04:20:58

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,050 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.4% in the 4th quarter, HoldingsChannel reports. The fund owned 131,718 shares of the company’s stock after buying an additional 9,050 shares during the period. UBS AM a distinct […] - 2025-06-10 04:20:48

Hennion & Walsh Asset Management Inc. Has $791,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA)

Hennion & Walsh Asset Management Inc. lowered its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,816 shares of the company’s stock after selling 3,099 shares during the […] - 2025-06-08 05:53:09

JMP Securities Reaffirms “Market Outperform” Rating for Kura Oncology (NASDAQ:KURA)

JMP Securities restated their market outperform rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $28.00 target price on the stock. Other equities research analysts have also issued reports about the stock. Barclays lowered their price target on shares of Kura Oncology […] - 2025-06-05 04:25:02

Man Group plc Takes $163,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)

Man Group plc acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 18,705 shares of the company’s stock, valued at approximately $163,000. Other institutional investors have also recently bought and sold shares of the company. Millennium Management LLC lifted its position […] - 2025-05-29 06:22:57

Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LP

Two Sigma Advisers LP grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 147.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 242,200 shares of the company’s stock after acquiring an additional 144,201 […] - 2025-05-29 05:16:54

Millennium Management LLC Increases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)

Millennium Management LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 180.1% during the fourth quarter, HoldingsChannel reports. The firm owned 2,367,148 shares of the company’s stock after buying an additional 1,521,954 shares during the period. Millennium Management LLC’s holdings in Kura Oncology were worth $20,618,000 at the end of the […] - 2025-05-21 05:46:49

Mizuho Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock Price

Kura Oncology (NASDAQ:KURA – Get Free Report) had its price objective decreased by stock analysts at Mizuho from $32.00 to $30.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s target price indicates a potential upside of 370.22% from the company’s […] - 2025-05-21 05:06:53

BNP Paribas Financial Markets Has $1.43 Million Position in Kura Oncology, Inc. (NASDAQ:KURA)

BNP Paribas Financial Markets boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 969.9% in the fourth quarter, Holdings Channel reports. The firm owned 163,559 shares of the company’s stock after purchasing an additional 148,272 shares during the period. BNP Paribas Financial Markets’ holdings in Kura Oncology were worth $1,425,000 […] - 2025-05-19 04:36:55

Wells Fargo & Company MN Has $305,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA)

Wells Fargo & Company MN grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 48.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,989 shares of the company’s stock after acquiring an additional 11,427 shares […] - 2025-05-07 06:20:47

Kura Oncology, Inc. (NASDAQ:KURA) Shares Purchased by MetLife Investment Management LLC

MetLife Investment Management LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 44,828 shares of the company’s stock after acquiring an additional 2,776 shares during the period. MetLife Investment Management LLC’s holdings in Kura Oncology were worth […] - 2025-05-07 05:28:47

Kura Oncology (NASDAQ:KURA) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $40.00 price objective on the stock. Several other brokerages also recently weighed in on KURA. JMP Securities reaffirmed a “market outperform” rating and set a $28.00 […] - 2025-04-29 04:28:55

Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Corebridge Financial Inc.

Corebridge Financial Inc. reduced its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,050 shares of the company’s stock after selling 2,721 shares during the quarter. Corebridge Financial Inc.’s holdings […] - 2025-04-11 04:54:48

Kura Oncology (NASDAQ:KURA) Given Outperform Rating at Wedbush

Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued to investors on Tuesday,RTT News reports. They currently have a $36.00 price objective on the stock. A number of other equities analysts have also recently weighed in on KURA. UBS Group dropped their price target […] - 2025-04-10 04:54:43

Kura Oncology, Inc. (NASDAQ:KURA) Stock Position Increased by Teacher Retirement System of Texas

Teacher Retirement System of Texas lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 19.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,749 shares of the company’s stock after acquiring an additional 2,285 shares during the quarter. Teacher Retirement System of Texas’ holdings in Kura Oncology were worth […] - 2025-04-03 04:16:48

Financial Comparison: Kura Oncology (NASDAQ:KURA) & Repare Therapeutics (NASDAQ:RPTX)

Kura Oncology (NASDAQ:KURA – Get Free Report) and Repare Therapeutics (NASDAQ:RPTX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations. Profitability This table compares Kura Oncology and […] - 2025-04-03 02:22:47

StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to “Buy”

StockNews.com upgraded shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday morning. KURA has been the subject of a number of other reports. Cantor Fitzgerald raised shares of Kura Oncology to a “strong-buy” rating in a research report on Tuesday, […] - 2025-03-27 05:00:50

Kura Oncology (NASDAQ:KURA) Stock Rating Lowered by StockNews.com

StockNews.com lowered shares of Kura Oncology (NASDAQ:KURA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. KURA has been the topic of a number of other research reports. Jefferies Financial Group lowered their target price on shares of Kura Oncology from $32.00 to $28.00 and set […] - 2025-03-19 04:52:47

20,331 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by AlphaQuest LLC

AlphaQuest LLC acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,331 shares of the company’s stock, valued at approximately $177,000. Several other large investors have also recently added to […] - 2025-03-17 06:04:56

Rhumbline Advisers Purchases 1,923 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

Rhumbline Advisers boosted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,991 shares of the company’s stock after acquiring an additional 1,923 shares during the period. Rhumbline Advisers’ holdings […] - 2025-03-07 07:20:52

Kura Oncology (NASDAQ:KURA) Raised to “Strong-Buy” at Cantor Fitzgerald

Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports. Several other research firms have also recently commented on KURA. HC Wainwright restated a “buy” rating and set a $40.00 target price on shares of Kura Oncology […] - 2025-03-06 06:20:01

Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $27.13

Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 04:46:47

Barclays PLC Has $3.23 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)

Barclays PLC boosted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 104.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 165,484 shares of the company’s stock after purchasing an additional 84,563 shares during the period. Barclays PLC’s holdings in Kura […] - 2025-02-11 06:42:48

Jennison Associates LLC Acquires Shares of 71,497 Kura Oncology, Inc. (NASDAQ:KURA)

Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 71,497 shares of the company’s stock, valued at approximately $623,000. Several other large investors also recently added to or reduced their stakes in KURA. Moody Aldrich Partners LLC lifted its […] - 2025-02-08 07:05:00

China Universal Asset Management Co. Ltd. Purchases 1,750 Shares of Kura Oncology, Inc. (NASDAQ:KURA)

China Universal Asset Management Co. Ltd. lifted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 11.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,489 shares of the company’s stock after buying an additional 1,750 shares during […] - 2025-02-04 06:53:04

Back to Listing

Disclaimer